Biotech

DRC Medicine Ltd to Merge with Ribbon Acquisition Corp.

DRC Medicine Ltd., an innovative healthcare and biotechnology company based in Tokyo, Japan, announced that it has entered into a business combination agreement with Ribbon Acquisition Corp., a special purpose acquisition company, DRC Medicine Inc., a Delaware company limited by shares and DRC Merger Inc., a Delaware company limited by shares and a directly owned subsidiary of DRC Medicine, which would result in DRC Medicine becoming a publicly-traded company. DRC Medicine Ltd. is an innovative healthcare and biotechnology company headquartered in Japan, focused on the research, development, and commercialization of advanced medical technologies that address significant global health challenges. The Company is best known for its proprietary Hydro Silver Titanium® technology, initially applied in consumer hygiene products such as masks and towels, and now being advanced to obtain medical device…